Dissertations / Theses on the topic 'Intellectual disability Genetic aspects'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 28 dissertations / theses for your research on the topic 'Intellectual disability Genetic aspects.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse dissertations / theses on a wide variety of disciplines and organise your bibliography correctly.
Murray, Aoife Maureen. "Investigating the role of ZDHHC9 in intellectual disability." Thesis, University of Cambridge, 2013. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.648223.
Full textMorgan, Vera Anne. "Intellectual disability co-occurring with schizophrenia and other psychiatric illness : epidemiology, risk factors and outcome." University of Western Australia. School of Psychiatry and Clinical Neurosciences, 2008. http://theses.library.uwa.edu.au/adt-WU2008.0209.
Full textMattioli, Francesca. "Identification of novel genetic causes of monogenic intellectual disability." Thesis, Strasbourg, 2018. http://www.theses.fr/2018STRAJ035/document.
Full textIntellectual disability (ID) is a group of neurodevelopmental disorders characterized by an extreme genetic heterogeneity, with more than 700 genes currently implicated in Mendelian forms of ID but still some are not yet identified. My PhD project investigates the genetic causes of these monogenic ID by using and combining different NGS techniques. By using this strategy, I reached a relative high diagnostic yield and identified several novel mutations (in AUTS2, THOC6) and genes (BRPF1, NOVA2, etc) involved in ID. For the less characterized ones, I performed functional investigations to prove their pathogenicity, delineate the molecular mechanisms altered and identify their role in this disease. Overall, this work improved and provided new strategies to increase the molecular diagnosis in patients with ID, which is important for their healthcare and better management. Furthermore, the identification and the characterization of novel mutations and genes implicated in ID better delineate the implicated pathophysiological mechanisms, opening the way to potential therapeutic targets
Zhao, Jin. "Sequence based identification of genetic variation associated with intellectual disability." Doctoral thesis, Uppsala universitet, Institutionen för immunologi, genetik och patologi, 2017. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-326283.
Full textBurbidge, Cheryl A. "The assessment of hyperactivity in genetic syndromes associated with intellectual disability." Thesis, University of Birmingham, 2005. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.422778.
Full textAl, Amri Ahmed Hamed Hamood. "Genetic basis of intellectual disability and schizophrenia in selected Omani and UK families." Thesis, University of Leeds, 2017. http://etheses.whiterose.ac.uk/18055/.
Full textLutter, Andrea Elizabeth. "The Impact of Rosa's Law on Describing Persons with Intellectual Disability." Case Western Reserve University School of Graduate Studies / OhioLINK, 2014. http://rave.ohiolink.edu/etdc/view?acc_num=case1398193968.
Full textTurnbull, David John. "Towards a collaborative ethic in intellectual disability services." Thesis, Queensland University of Technology, 1998.
Find full textCasha, Sonja. "Speaking of angels : intellectual disability, identity and further education in Malta." Thesis, University of Birmingham, 2016. http://etheses.bham.ac.uk//id/eprint/6601/.
Full textShaw, Rebecca. "Hyperactive, impulsive, distractible and inattentive behaviour in children with genetic syndromes associated with intellectual disability." Thesis, University of Birmingham, 2007. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.485988.
Full textAndrew, Erin H. "Parental Experiences When CMA is Ordered by a Geneticist vs. Non-geneticist." University of Cincinnati / OhioLINK, 2017. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1491305824301482.
Full textPinto, Irene Plaza. "A importância dos resultados do CMA no aconselhamento genético das famílias com probandos apresentando deficiência intelectual." Pontifícia Universidade Católica de Goiás, 2015. http://localhost:8080/tede/handle/tede/2385.
Full textIntellectual disability is characterized by a significant decrease in both cognitive and adaptive functions, affecting 1-3% of the general population. Worldwide is a major socioeconomic problem, with a highly heterogeneous and variable etiology, which may include environmental factors, disorders Mendelian and chromosomal abnormalities, presented alone or in combination. Single gene and chromosomal disorders are considered the cause of intellectual deficiency in 7-37% of cases, while submicroscopic copy number variation occur in 5-15% of cases, especially when associated with multiple congenital abnormalities, and-or dysmorphisms. Genomic microarrays have been extensively used in the studying the genetic causes of intellectual disability, and the chromosomal microarray analysis is recommended as the first-tier cytogenetic diagnostic test for patients with intellectual disability-global developmental delay, autism spectrum disorders and-or multiple congenital anomalies. Genetic counseling is a process that deals with the occurrence or risk of occurrence of a genetic disorder in a family, helping them to understand the contribution of this heritage, involving education and reproductive aspects. The goals include facilitation of informed autonomous choices, education, which includes information on options (available, risks and limitations of those options), as well as provision of emotional support. Promoting, thus, autonomy and adaptation to the diagnosis, with the central tenet the nondirectiveness, requiring the genetic counselor to maintain a neutral stance, supporting and respecting the patient s personal values and decisions. Families of people diagnosed with genetic disorders need to be aware of the importance of going through the process of genetic counseling, and this should be done continuously and according to the need that the facts indicate, with the primary objective the promotion of health and the quality of life.
Deficiência intelectual é caracterizada por uma diminuição significativa em ambas funções cognitivas e adaptativas, afetando de 1 3 % da população em geral. É mundialmente um dos principais problemas sócio-econômicos, com uma etiologia altamente heterogênea e variável, podendo incluir fatores ambientais, desordens mendelianas e anormalidades cromossômicas, apresentados sozinhos ou combinados. Desordens de um único gene e cromossômicas são consideradas a causa de deficiência intelectual em 7-37% dos casos, enquanto que variação número de cópias submicroscópicas ocorrem em 5-15% dos casos, especialmente quando estão associadas com anormalidades congênitas múltiplas e-ou dismorfismos. Microarranjos genômicos têm sido extensivamente usados no estudo das causas genéticas da deficiência intelectual, sendo a análise cromossômica em microarranjos recomendada como teste diagnóstico de primeira escolha para pacientes com deficiência intelectual-atraso no desenvolvimento global, desordem do espectro do autista e-ou anormalidades congênitas múltiplas. Aconselhamento genético é um processo que lida com a ocorrência ou o risco de ocorrência de uma doença genética na família, ajudando-a a compreender a contribuição desta herança, envolvendo aspectos educacionais e reprodutivos. Sua prática visa a facilitação de escolhas autônomas informadas, num processo educacional, incluindo informações sobres as opções (disponibilidade, riscos e limitações destas opções), bem como o fornecimento de um suporte emocional. Promovendo, dessa forma, autonomia e adaptação ao diagnóstico, tendo como dogma central a não diretividade, exigindo do conselheiro geneticista uma posição neutra, apoiando e respeitando valores e decisões pessoais do paciente. Famílias de pessoas diagnosticadas com doenças genéticas precisam ser esclarecidas sobre a importância de passarem pelo processo de aconselhamento genético, e este deve ser feito de forma contínua e de acordo com a necessidade que os fatos indicarem, tendo o objetivo primário a promoção da saúde e a qualidade de vida.
Chanias, Angelos. "The effects of exercise programming on health-related physical fitness of individuals with an intellectual disability : a meta-analysis of studies." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1997. http://www.collectionscanada.ca/obj/s4/f2/dsk2/ftp03/MQ29535.pdf.
Full textJoelle, Dountio Ofimboudem. "The protection of traditional knowledge: challenges and possibilities arising from the protection of biodiversity in South Africa." University of the Western Cape, 2011. http://hdl.handle.net/11394/2887.
Full textTraditional Knowledge (TK) is the long standing wisdom, teachings and practices of indigenous communities which have been passed on orally, in the majority of cases, from generation to generation. TK is expressed in the form, medicine, agriculture, understanding of the ecology, music, dance, stories, folklore, poetry, spiritual, cultural and artistic expressions, and knowledge relating to bio-diversity. This thesis focuses on plant bio-diversity, as part of TK, and the problem of bio-piracy. We attempt a definition of TK; its characteristics; possible measures that can be taken to ensure its protection; and challenges that are likely to be faced in seeking to ensure its protection, first at the global level, then with particular attention to South Africa. Some of the suggested measures include the enactment of sui generis laws to protect plant biodiversity, rather that the adaptation of the existing IP regime. Some of the challenges include unwillingness of some countries to participate in international initiatives, like the US, which is not even a signatory of the CBD, and the difficulty of identifying the persons in whom ownership of the TK should be vested when it is possessed by many communities. This issue is a very sensitive one because there have been numerous cases of bio-piracy in developing countries perpetrated by corporations from industrialised countries. Some of the notable examples of bio-piracy include; The Neem tree from India whose products are used in medicine, toiletries and cosmetics; the Ayahuasca a vine used in India for religious and healing ceremonies; the Asian Turmeric plant used in cooking, cosmetics and medicine, the Hoodia Cactus plant in the Kalahari Desert of southern Africa used by the San people to stave off hunger. These instances have given rise to increased talks about the necessity of a law on the protection of TK relating to bio-diversity in general at the international, regional and national levels. The World Intellectual Property Organisation (WIPO) is working on enacting measures to ensure the protection and conservation of TK at the international level; in 2002 it created nine fact finding commissions on TK in general. These fact finding missions on TK innovation and creativity were undertaken with the intention of seeking possibilities of protecting the intellectual property rights of TK holders. In 2002, The WIPO Intergovernmental Committee on Intellectual Property and Genetic Resources, Traditional Knowledge and Folklore (IGC) was created to continue with this task. The 1993 Convention on Biodiversity (CBD) encourages States to enact measures to implement its provisions on the protection of knowledge, innovations and practices of indigenous and local communities. This trend in protection of TK relating to biological resources has been followed by the Nagoya Protocol of October 2010. The World Trade Organisation (WTO) also makes mention of protecting plant varieties. The research suggests that one could use both Intellectual Property Rights and Sui Generis measures to address and secure protection of TK, and provide compensation to holders for the use of the intellectual property.
South Africa
Mason, Nicholas Craig. "Forging a New Global Commons Introducing common property into the global genetic resource debate." Thesis, University of Canterbury. School of Political Science and Communication, 2004. http://hdl.handle.net/10092/904.
Full textMcAllister, J. N. "The employment experiences of an adult with Down Syndrome." Thesis, Stellenbosch : Stellenbosch University, 2008. http://hdl.handle.net/10019.1/2870.
Full textThe research aims to investigate the employment experiences of a South African adult with Down syndrome, and to explore whether this improves the quality of life for this adult across several areas of functioning. This qualitative research design is situated within an interpretive research paradigm. A Case study method was used. Data have been produced using multiple sources and techniques to enhance validity. These include interviews, observation, field notes and questionnaires. Full account has been taken of ethical considerations. The case study shows that this adult with Mosaic Down syndrome and intellectual disability, who is permanently employed in the open labour market, is seen as an asset by the company. Training and support have benefited him and extra supervision and attention needed are minimal. His skills, attitudes, and family support have also enhanced his quality of life. This adult's employment experiences have contributed to a culture of acceptance of and openness to intellectual disability in the formal industrial sector. This is an example of what can be accomplished regardless of intellectual disability. As this is a case study the generalisation of the findings are limited.
Piazzon, Flavia Balbo. "Investigação clínica e citogenética molecular em pacientes com atraso de desenvolvimento neuropsicomotor associado à malformação congênita." Universidade de São Paulo, 2016. http://www.teses.usp.br/teses/disponiveis/5/5144/tde-24032016-145538/.
Full textIntroduction: The recent technological advances on DNA-based techniques have established in modern medicine good opportunities to elucidate undefined clinical cases in patients with complex chromosomal microrearrangements. The performance of MLPA (Multiplex ligation-dependent probe amplification) technique together with array technologies (WGAS - whole genome array screening) created the possibility of one single experiment to analyze different regions of interest in the human genome. Objective: Patients with psychomotor delay (PSMD) associated with multiple congenital anomalies who had normal or inconclusive G-band-karyotype (MCA) were studied in order to understand the genotype-phenotype correlations. Material and methods: This study involved 71 patients with psychomotor delay (PSMD) associated with multiple congenital anomalies (MCA) analyzed by MLPA (P036 and P064 kits), followed by WGAS different platforms (Agilent, Affymetrix e Illumina®). Results: Among 33 patients with pathogenic and uncertain (VOUS) copy number variations (CNV) were found: 12 deletions, 5 duplications and 16 concomitant duplication and deletion (dup/del). There were 29 patients with conclusive pathogenic findings, 4 patients with VOUS and 16 patients with normal array, but others 23 patients with benign results, which means there is no gene content in the region involved, or because these genes were not linked to phenotype, or even due to CNVs inherited of healthy parents. From the whole casuistic, 4 individuals presented loss of heterozygosity (LOH) regions. Conclusions: The use of a combined strategy of analysis (MLPA - WGAS) with a high capacity to detect pathogenic CNVs allows unraveling microscopic imbalances, and consequently, offers an adequate clinical correlation for patients not previously diagnosed by classical cytogenetics. In conclusion, this study suggests a new model for the combined application of these techniques, which represents an optimal alternative for a genomic screening and diagnostic establishment in patients with rare complex disorders and their families
Cavallin, Mara. "Physiopathologie moléculaire et cellulaire des anomalies du développement du cortex cérébral : le syndrome d'Aicardi WDR81 mutations cause extreme microcephaly and impair mitotic progression in human fibroblasts and Drosophila neural stem cells TLE1, a key player in neurogenesis, a new candidate gene for autosomal recessive postnatal microcephaly Mutations in TBR1 gene leads to cortical malformations and intellectual disability Aicardi syndrome: Exome, genome and RNA-sequencing of a large cohort of 19 patients failed to detect the genetic cause Recurrent RTTN mutation leading to severe microcephaly, polymicrogyria and growth restriction Recurrent KIF2A mutations are responsible for classic lissencephaly Recurrent KIF5C mutation leading to frontal pachygyria without microcephaly Rare ACTG1 variants in fetal microlissencephaly De novo TUBB2B mutation causes fetal akinesia deformation sequence with microlissencephaly: An unusual presentation of tubulinopathy A novel recurrent LIS1 splice site mutation in classic lissencephaly Further refinement of COL4A1 and COL4A2 related cortical malformations Prenatal and postnatal presentations of corpus callosum agenesis with polymicrogyria caused By EGP5 mutation Delineating FOXG1 syndrome from congenital microcephaly to hyperkinetic encephalopathy Delineating FOXG1 syndrome: From congenital microcephaly to hyperkinetic encephalopathy." Thesis, Sorbonne Paris Cité, 2019. https://wo.app.u-paris.fr/cgi-bin/WebObjects/TheseWeb.woa/wa/show?t=2213&f=18201.
Full textMalformations of cortical development (MCD) are a major cause of intellectual disability and drug-resistant epilepsy. Next Generation Sequencing (NGS) has considerably improved the identification of the molecular basis of non-syndromic MCD. However, certain forms, including complex MCD, remain unexplained. My PhD project aimed to improve the understanding of complex MCD using two disorders: Microlissencephaly (MLIS) and Aicardi Syndrome (AIC), the latter associating brain and eye malformations and only reported in girls. Trio Whole Exome Sequencing (WES) performed in 16 MLIS families allowed me to identify and functionally characterize a new MLIS gene, WDR81, in which mutations lead to cell cycle alteration. Moreover, using the same strategy, I was able to identify a pathogenic homozygous variant in TLE1 in a patient from consanguineous family with a postnatal microcephaly, suggestive of a FOXG1-like presentation. Interestingly, TLE1 is a major partner of FOXG1, a gene involved in maintaining the balance between progenitor proliferation and differentiation. In parallel, my work allowed me to redefine the phenotypic spectrum associated with RTTN, EPG5, COL4A1 and COL4A2, TBR1, KIF5C, KIF2A and FOXG1. The second part of my PhD program was aimed at identifying the genetic basis of AIC in an international cohort of 19 patients. After excluding a skewed X chromosome inactivation and the presence of chromosomal rearrangements, I performed WES in trios. The analysis of the data from WES did not allow me to identify any recurrent variants. I therefore tested a new approach combining Whole Genome Sequencing (WGS) and RNA-Sequencing (RNA-Seq) on fibroblast cells. I identified a number of deregulated transcripts implicated in brain and eye development. I compared the results of this analysis with the WGS analysis in order to find variants in these candidate genes. In conclusion, these studies have improved the knowledge of the molecular basis of complex MCD, such as TLE1 in postnatal microcephaly, and revealed the pathogenic mechanisms such as WDR81 in cell cycle progression and EPG5 in endosomes and autophagy. My work has also generated a collection of NGS data (WES, WGS and RNA-Seq) that will be shared in an international consortium to develop new analytical strategies, in particular for the non-coding DNA regions. This novel strategy provides opportunities to improve understanding of the cellular mechanisms involved in brain and eye development
Belarde, James Anthony. "Development of a mouse model of a novel thin lissencephaly variant." Thesis, 2021. https://doi.org/10.7916/d8-t4g7-s810.
Full textLopes, Fátima Daniela Teixeira. "Deciphering the genetic basis of intellectual disability through unbiased genomic approaches." Doctoral thesis, 2017. http://hdl.handle.net/1822/48636.
Full textNeurodevelopmental disorders arise in childhood and are life-long condition that represents many challenges to the patients, their families and society, through public services. Among those, intellectual disability affects 1% of the population in developed countries, encompassing the most common group of neurodevelopmental disorders. Intellectual disability is characterized by cognitive impairment and limitation in functioning capacity and can be cause by exogenous factors (such as maternal alcohol abuse during pregnancy, infections and malnutrition) but it is well established that genetic factors play important roles in its pathophysiology. In ID, as in many others disorders, detecting the underlying genetic cause is a complex and time consuming process yet of great value to the patients and families because it allows the possibility of genetic counseling. In the last years, advances in two major types of technologies allowed great advances in the discovery of new genomic anomalies causing intellectual disability: array comparative genomic hybridization and massive parallel sequencing. Array comparative genomic hybridization allowed a high resolution genome wide investigation of copy number variations leading to the discovery of many novel microdeletion/microduplication syndromes. Massive parallel sequencing evolved in a way that the sequencing of all the genome (or, at a lower cost, all the exons) is now possible to perform in any genetic laboratory in a time and cost-efficient manner, allowing the discovery of many novel variants in previously known and newly discovered intellectual disability genes. These two approaches have provided significantly new insights into the biological pathways associated with intellectual disability and tremendously improved the diagnostic process. In this study we applied these two technologies to the study of the genetic basis of neurodevelopmental disorders. We studied a big group of patients with idiopathic intellectual disability by aCGH (which included two cohorts with different selection criteria - a research and a clinical cohort), a group of patients with a Rett syndrome-like clinical presentation by exome sequencing and re-analyzed exome data from a pediatric heterogeneous cohort. Array comparative genomic hybridization allowed the detection of previously known microdeletion and microduplication syndromes in patients with until then unexplained intellectual disability, with yields of 13% in the research cohort and 18% in the clinical cohort. Importantly it also allowed the discovery of 12 new loci likely to cause neurodevelopmental disease as well as the gathering of additional patients with overlapping genomic imbalances and phenotypic features, allowing the definition of new (rare) syndromes. Massive parallel sequencing – more specifically whole exome sequencing - was applied to a group of patients sharing similar clinical presentation (Rett syndrome-like) and proved to be very effective, leading to the identification of five new genes possibly involved in intellectual disability (HTT, SMARCA1, GABBR2, RHOBTB2 and EIF4G1). It is currently an accepted fact however, that the data generated by exome sequencing at a certain point in time, may not retrieve the genetic cause of the disease. This limitation is often related with the lack of information regarding the genes detected. Given the always increasing knowledge on genes and pathways involved in neurodevelopmental disorders, the need for reevaluation of older and previously unsolved cases emerges. This strategy was also applied in this work and proven to be extremely useful in the clinical context, adding new patients to help establish the relevance of candidate disease genes and raising new candidate genes (DNAJC21, MYOD1 and PAX7). In summary, this work helped to clarify the genetic basis of disease in several patients until then unsolved, as well as to bring forward new candidate loci and genes for intellectual disability and other neurodevelopmental disorders.
This work was supported by Foundation for Science and Technology (FCT) through a PhD studentship (SFRH/BD/90167/2012) and by the Seventh Framework Programme (FP7/2007- 2013) under grant agreement no. 262055. This work was also supported by the FEDER through the Operational Programme Competitiveness Factors - COMPETE and the national funds through the FCT - Foundation for Science and Technology within the projects (POCI-01-0145-FEDER-007038), and by the project NORTE01- 0145-FEDER-000013, supported by Norte Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF).
As perturbações do neurodesenvolvimento surgem na infância e constituem doenças crónicas, criando inúmeras limitações para os doentes, famílias e sociedade – sob a forma de serviços públicos. Entre estas, o défice intelectual (previamente designado atraso mental) afecta 1% da população dos países desenvolvidos, sendo o tipo de doença do neurodesenvolvimento mais comum. O défice intelectual é caracterizado por uma limitação cognitiva e funcional e pode ser causado por factores exógenos (como o consumo materno de álcool durante a gravidez, infeções e malnutrição), sendo no entanto fatores genéticos reconhecidos como muito importantes para a patofisiologia do défice cognitivo. Neste grupo de doenças, assim como em muitas outras, a deteção da causa genética é um processo complexo e demorado mas de grande valor para os doentes e famílias, uma vez que abre portas á possibilidade de aconselhamento genético. Nos últimos anos, avanços em duas grandes tecnologias de diagnóstico genético permitiram a descoberta de novas anomalias genéticas associadas e défice intelectual: array de hibridação genómica comparativa e sequenciação paralela massiva. Os arrays de hibridação genómica comparativa permitiram a análise de alta resolução de todo o genoma na busca de alterações do número de cópias, o que resultou na descoberta de várias novas síndromes associadas microdeleções/microduplicações. A sequenciação paralela massiva desenvolveu-se de uma forma em que a sequenciação de todo o genoma (ou, de forma mais económica, de todos os exões) é agora possível realizar em qualquer laboratório de genética em tempo útil e com um bom custo/benefício, permitindo a descoberta de variantes tanto em genes já conhecidos como em novos genes causadores de défice intelectual. Estas duas abordagens contribuíram significativamente para novas descobertas em vias moleculares associadas com défice intelectual e para o melhoramento do seu diagnóstico. Neste estudo aplicamos estas duas tecnologias ao estudo da base genética de doenças do neurodesenvolvimento. Estudamos por aCGH um grande grupo de doentes com défice intelectual idiopático (o que incluiu dois coortes com diferentes critérios de seleção – um coorte de investigação e um coorte clinico), estudamos por sequenciação de exoma um grupo de doentes com sintomatologia semelhante à síndrome de Rett, e reanalisamos dados de exoma de um grupo heterogéneo de doentes pediátricos. O array de hibridação genómica comparativa permitiu a deteção de microdeleções e microduplicações já conhecidas em doentes até à data com défice intelectual idiopático, com uma taxa de sucesso de 13% no coorte de investigação e de 18% no coorte clinico. Foi também possível a deteção de novos 12 novos loci passíveis de causar doença do neurodesenvolvimento assim como a recolha de doentes adicionais com desequilíbrios genómico e fenótipo sobreponíveis, contribuindo para a definição de novas síndromes raras. A sequenciação paralela massiva – em particular a sequenciação do exoma - foi aplicada a um grupo de doentes com apresentação clinica semelhante (síndrome de Rett-like), revelando-se bem-sucedida na identificação de cinco novos genes possivelmente envolvidos no défice intelectual (HTT, SMARCA1, GABBR2, RHOBTB2 e EIF4G1). Atualmente é facto aceite que os dados gerados por sequenciação do exoma numa determinada altura poderão não levar á descoberta da causa genética da doença. Esta limitação está muitas vezes relacionada com a escassez de informação relativamente aos genes encontrados. Tendo em conta o sempre crescente conhecimento relativo a genes e vias moleculares envolvidas em doenças do neurodesenvolvimento, surge a necessidade de reavaliação de casos antigos não solucionados. Esta estratégia foi também aplicada neste trabalho e provando ser de grande utilidade no contexto clinico, levando à deteção de mais doentes que contribuem para a determinação dos genes candidatos relevantes assim como para a deteção de novos genes candidatos (DNAJC21 , MYOD1 and PAX7 ). Em resumo, este trabalho contribuiu para a clarificação da causa genética de doença em vários doentes até à data não resolvidos, e propõe novos loci candidatos e genes que contribuem para o défice intelectual e outras doenças do neurodesenvolvimento.
Munson, Adrianna. "Working on Life: Autonomy and Dependence for People with Intellectual Disability." Thesis, 2021. https://doi.org/10.7916/d8-dq96-gp02.
Full textNoor, Abdul. "Molecular Genetic Study of Autism and Intellectual Disability Genes on the X-chromosome." Thesis, 2012. http://hdl.handle.net/1807/32783.
Full textMeredith, Jo. "Programmed generalization of reduced tantrum behaviors in epilepsy with severe intellectual disability." Master's thesis, 1990. http://hdl.handle.net/1885/141411.
Full text"Inherited metabolic diseases in Hong Kong." Chinese University of Hong Kong, 1995. http://library.cuhk.edu.hk/record=b5888258.
Full textThesis (Ph.D.)--Chinese University of Hong Kong, 1995.
Includes bibliographical references (leaves 225-243).
Title --- p.1
Abstract --- p.2
Acknowledgments --- p.4
Contents --- p.5
Abbreviations --- p.10
List of Figures --- p.12
List of Tables --- p.15
Chapter Chapter 1 --- Review on Inherited Metabolic Diseases --- p.18
Chapter 1.1 --- Development of the concept of inherited metabolic diseases (IMD) --- p.18
Chapter 1.2 --- Frequency of inherited metabolic diseases --- p.20
Chapter 1.3 --- Molecular basis of mutations in inherited metabolic diseases --- p.22
Chapter 1.3.1 --- Point mutations --- p.22
Chapter 1.3.2 --- Small deletions and insertions --- p.25
Chapter 1.3.3 --- large deletions or duplications --- p.26
Chapter 1.4 --- Pathological consequences of protein defect resultingin IMD --- p.27
Chapter 1.4.1 --- End product --- p.28
Chapter 1.4.2 --- Precursor accumulation --- p.28
Chapter 1.4.3 --- Unusual metabolites --- p.29
Chapter 1.5 --- Heterogeneity of inherited metabolic diseases --- p.29
Chapter 1.5.1 --- Genetic heterogeneity --- p.29
Chapter 1.5.2 --- Variations of expression in different cells --- p.31
Chapter 1.6 --- Diagnosis of inherited metabolic diseases --- p.32
Chapter 1.6.1. --- Biochemical investigations --- p.32
Chapter 1.6.2 --- Identification of accumulated or missing metabolites --- p.33
Chapter 1.6.3 --- Direct analysis of enzymes and proteins --- p.34
Chapter 1.6.4 --- Molecular investigations --- p.34
Chapter 1.7 --- Treatment of inherited metabolic diseases --- p.40
Chapter 1.7.1 --- Treatment at the clinical phenotype level --- p.41
Chapter 1.7.2 --- Treatment at the metabolite level --- p.41
Chapter 1.7.3 --- Treatment at the dysfunctional protein level --- p.43
Chapter 1.7.4 --- Transplantation --- p.44
Chapter 1.7.5 --- Gene therapy --- p.45
Chapter 1.8 --- Inherited metabolic diseases in Hong Kong --- p.47
Chapter 1.9 --- General Aim --- p.48
Chapter Chapter 2 --- Study of Inherited Metabolic Diseases in Mentally Retarded Patients --- p.49
Chapter 2.1 --- Introduction --- p.49
Chapter 2.2 --- Aim --- p.52
Chapter 2.3 --- Materials --- p.53
Chapter 2.3.1 --- Standards --- p.53
Chapter 2.3.2 --- Chemical reagents --- p.53
Chapter 2.3.3 --- Derivatization reagents --- p.54
Chapter 2.3.4 --- Major equipment --- p.54
Chapter 2.4 --- Clinical materials --- p.56
Chapter 2.4.1 --- Subjects --- p.55
Chapter 2.4.2 --- Blood and urine samples --- p.56
Chapter 2.5 --- Methods --- p.57
Chapter 2.5.1 --- General biochemistry tests --- p.57
Chapter 2.5.2 --- Metabolic screening tests --- p.57
Chapter 2.5.3 --- Two-dimensional thin layer chromatography --- p.53
Chapter 2.5.4 --- Identification of urinary organic acids by gas chromatography mass spectroscopy --- p.59
Chapter 2.5.5 --- Amino acid analysis by high performance liquid chromatography --- p.66
Chapter 2.6 --- Results --- p.71
Chapter (A) --- Methodological Aspects
Chapter 2.6.1 --- Identification of urinary organic acids by gas chromatography-mass spectroscopy (GC-MS) --- p.71
Chapter 2.6.2 --- Amino acid analysis by high performance liquid chromatography (HPLC) --- p.86
Chapter (B) --- Patient Investigations
Chapter 2.6.3 --- General biochemistry tests --- p.107
Chapter 2.6.4 --- Serum amino acid profiles --- p.113
Chapter 2.6.5 --- Urinary organic acid analysis --- p.115
Chapter 2.6.6 --- Case reports --- p.119
Chapter 2.7 --- Discussion --- p.123
Chapter 2.7.1 --- Identification of urinary organic acids by gas chromatography-mass spectroscopy (GC-MS) --- p.123
Chapter 2.7.2. --- Amino acid analysis by high performance liquid chromatography (HPLC) --- p.130
Chapter 2.7.3 --- Identification of inherited metabolic diseases (IMD)in an institutionalized mentally retarded patients --- p.136
Chapter Chapter 3 --- Molecular Investigation of Maple Syrup Urine Disease --- p.140
Chapter 3.1 --- Introduction --- p.140
Chapter 3.1.1 --- Branched chain amino acids (BCAA) --- p.140
Chapter 3.1.2 --- Metabolism of branched chain amino acids --- p.142
Chapter 3.1.3 --- Maple syrup urine disease (MSUD) --- p.144
Chapter 3.1.4 --- Classification of maple syrup urine disease --- p.146
Chapter 3.1.5 --- Screening and diagnosis of maple syrup urine disease --- p.148
Chapter 3.1.6 --- Treatment of maple syrup urine disease --- p.150
Chapter 3.1.7. --- Branched chain a-ketoacid dehydrogenase complex (BCKDH) --- p.151
Chapter 3.1.8 --- "Gene features of human E1α,E1β and E2 subunitsin branched chain α-ketoacid dehydrogenase complex" --- p.153
Chapter 3.1.9 --- Molecular defects of the BCKDH gene complex --- p.156
Chapter 3.1.10 --- MSUD in Hong Kong --- p.161
Chapter 3.2 --- Aim --- p.163
Chapter 3.3 --- Materials --- p.164
Chapter 3.3.1 --- Source of skin fibroblasts --- p.164
Chapter 3.3.2 --- Enzymes --- p.164
Chapter 3.3.3 --- DNA markers --- p.164
Chapter 3.3.4 --- Reagent Kits --- p.165
Chapter 3.3.5 --- Primers --- p.165
Chapter 3.3.6 --- Chemical reagents --- p.165
Chapter 3.3.7 --- Nitrocellulose membrane --- p.166
Chapter 3.3.8 --- Antiserum for Western blotting --- p.166
Chapter 3.3.9 --- Radioisotopes --- p.166
Chapter 3.4 --- Methods --- p.168
Chapter 3.4.1 --- Preparation of buffers and solutions --- p.168
Chapter 3.4.2 --- Agarose gel electrophoresis --- p.170
Chapter 3.4.3 --- Preparation of native polyacrylamide gel --- p.171
Chapter 3.4.4 --- Preparation of sodium dodecyl sulfate (SDS) polyacrylamide gel --- p.172
Chapter 3.4.5 --- Preparation of denaturing polyacrylamide gel --- p.173
Chapter 3.4.6 --- Branched chain α-ketoacid dehydrogenase complex enzyme assay --- p.173
Chapter 3.4.7. --- Identification of the affected subunits in BCKDH complex of MSUD patient and her family members --- p.176
Chapter 3.4.8 --- Screening of mutation in the BCKDH subunits by RT-PCR-SSCP --- p.178
Chapter 3.4.9 --- Mutation analysis of whole cDNA fragments of Elα, Elβ and E2 subunits by ds DNA cycle sequencing --- p.184
Chapter 3.5 --- Results --- p.188
Chapter 3.5.1 --- Branched chain α-ketoacid dehydrogenase complex enzyme assay --- p.188
Chapter 3.5.2 --- Identification of the affected subunits in BCKDH complex ofMSUD patient and her family members --- p.188
Chapter 3.5.3 --- Screening of mutation in the BCKDH subunits by RT-PCR-SSCP --- p.192
Chapter 3.5.4 --- "Mutation analysis of whole cDNA fragments of Ela, Elβ and E2 subunits by ds DNA cycle sequencing" --- p.204
Chapter 3.6 --- Discussion --- p.210
Chapter 3.6.1 --- BCKDH activity in the MSUD patient and her family members --- p.210
Chapter 3.6.2 --- Investigation of the mutation sites --- p.212
General Conclusion --- p.222
Appendix --- p.224
References --- p.225
Chen, Pin-Hsuan, and 陳品萱. "Identification of genetic aberrations in children with global developmental delay/ intellectual disability through detecting DNA copy number changes and whole exome sequencing." Thesis, 2019. http://ndltd.ncl.edu.tw/handle/x9mhcg.
Full text國立陽明大學
生命科學系暨基因體科學研究所
107
Developmental delay (DD) describes the condition when a child reaches developmental milestones in cognitive, speech/language, fine/gross motor, emotional, social/personal skills and activities of living later than the expected time during infancy and early childhood. Multiple factors may contribute to such delay. Intellectual disability (ID) may also be reflected as DD in early childhood. Clinically, when evaluating a child during early intervention, the pediatrician may consider the probability of genomic aberrations after ruling out socio-psychological or environmental factors. Copy number variations (CNVs) have been regarded as one of the major causes of DD. While array comparative genomic hybridization (aCGH) has been the current golden standard of CNV detection, next generation sequencing (NGS) techniques have evolved into a novel strategy for studying the genetic basis of human diseases, facilitating comprehensive characterization of genomic aberrations, inclusive of both CNVs and single nucleotide variants (SNVs), and analysis of high-resolution sequence data. The aim of this study is to determine the efficiency of whole exome sequencing (WES) as a first-tier diagnostic test in comparison with aCGH for DD. We have enrolled 322 subjects diagnosed with global developmental delay or intellectual disability of unknown cause. All individuals have completed aCGH tests (Positive rate: 17.1%). WES was performed on 34 cases, 24 of whom include both parents, with Agilent SureSelect target enrichment system using Illumina HiSeq2000. Analysis of WES data was conducted using Varseq v2.1.0. In cases whose aCGH tests revealed no positive findings, trio analyses were conducted in hopes of identifying causal variants most closely related to the conditions in the afflicted individuals. We have discovered 4 known rare pathogenic variants that may contribute to GDD/ID out of the 14 trios analyzed so far; they are TUBA1A (p.Arg214His), TMEM240 (p.Val115Met), TUBB2B (p.Ala248Val), and SMARCA2 (p.Pro883Leu). Moreover, 2 of these variants, TUBA1A (p.Arg214His) and SMARCA2 (p.Pro883Leu), correspond with the clinical phenotypes of the affected children, lissencephaly 3 and Nicolaides-Baraitser syndrome, respectively. Furthermore, CNVs in regions that are previously reported to be linked with DD/ID were also discovered in 12 of the cases. We have also included 10 singletons with positive findings in aCGH tests in order to determine the consistency in CNV detection between aCGH and WES tests. Out of the 13 CNVs called using aCGH, we detected CNVs in 11 regions by analyzing WES data. It is also noticed that CNV calling in WES data is more powerful in calling smaller CNV events. Among the 14 trios and 10 probands that have been analyzed so far, 115 CNVs with p-values<0.01 were called per case on average. Spans of these CNVs ranged from 119bp to 15Mbp, with approximately 91 CNVs <100kb, 23 CNVs 100kb-1Mb, and 1 CNVs >1Mb in each case. Duplications account for 65.0% confident CNV calls. Further validation by real-time quantitative PCR (qPCR) was conducted to confirm the precision and accuracy of CNV detection results by WES. CNV calls were divided into 6 strata according to their types and spans. In the 14 trios and 10 singletons, 1% of CNV calls have been drawn from each stratum (30 out of the total 2764 CNVs) for validation, 2 of which were detected in aCGH-negative cases and were previously reported to be associated with DD/ID, and 3 of which lay in the genomic regions that were previously called using aCGH. A total of 12 CNVs (40%) out of the 30 tested CNVs have at least one region that have RQ values that are suggestive or indicative of their CNV types (losses or gains). Here we shall demonstrate the capacity of WES for detecting CNVs and SNVs. WES may be considered a promising first-tier diagnostic tool for its versatility, moderate cost, and the potential to reduce diagnostic odyssey.
Mucha-Le, Ny Bettina E. "Clarification of the role of the TBC1D24 gene in human genetic conditions." Thesis, 2020. http://hdl.handle.net/1866/25193.
Full textPathogenic variants in the TBC1D24 gene are associated with genetic disorders, the majority of which are transmitted in an autosomal recessive manner. The phenotypes are variable in terms of clinical presentation and severity. The most severe forms cause epileptic encephalopathy (EIEE16) or DOORS syndrome which is marked by deafness, abnormalities of the nails and fingers, intellectual deficit and convulsions which are often difficult to control. Other forms of epilepsy include EPRPDC (Rolandic epilepsy with paroxysmal exercise-induce dystonia and writer's cramp), FIME (familial infantile myoclonic epilepsy), and PME (progressive myoclonus epilepsy). A specific missense variant is associated with autosomal dominant deafness (DFNA65) which develops in adulthood. A review of the literature of the published phenotypes observed in individuals with pathogenic variants in the TBC1D24 gene is presented here with recommendations for the clinical management of these patients. In addition, a group of eight patients with intellectual disability and epilepsy who share a microdeletion on chromosome 1613.3 containing the TBC1D24 gene were characterized in order to define a new genetic syndrome. The critical region contains TBC1D24, ATP6V0C and PDPK1. The significantly similar phenotype shared by the eight individuals suggests that haploinsufficiency for TBC1D24, ATP6V0C and PDPK1 causes a new genetic syndrome. Knowledge of the genes essential for the phenotype in this cohort helps in the identification of new candidate genes for intellectual disability and epilepsy.
O'Grady, Lynette. "The world of adolescence : using photovoice to explore psychological sense of community and wellbeing in adolescence with and without an intellectual disability." Thesis, 2008. https://vuir.vu.edu.au/1575/.
Full textDountio, Ofimboudem Joelle. "The protection of traditional knowledge: challenges and possibilities arising from the protection of biodiversity in South Africa." Thesis, 2011. http://etd.uwc.ac.za/index.php?module=etd&action=viewtitle&id=gen8Srv25Nme4_9133_1363011819.
Full text